Overview
Dr. James Suliburk is a board-certified endocrine surgeon specializing in the treatment of tumors of the thyroid, parathyroid, and adrenal gland. He is an Associate Professor and Chief of Endocrine Surgery - Surgical Oncology at Baylor College of Medicine, where he is also Medical Director of Ambulatory Surgery Therapeutics (CfAST) in BCM’s Department of Surgery; and is a member of the Dan L Duncan Comprehensive Cancer Center.Dr. Suliburk’s clinical interests include: thyroid nodules; goiter; Graves’ disease; thyroid cancer; hyperparathyroidism; adrenal masses; pheochromocytoma; Cushing’s, Conn’s diseases; minimally invasive parathyroidectomy and thyroidectomy; traditional open thyroidectomy; central, selective and modified radical neck dissection; single incision laparoscopic adrenalectomy; and traditional laparoscopic adrenalectomy. His research interests include: clinical outcomes in endocrine surgery in underserved and minority populations; outcomes in acute care and trauma surgery; and the application of mobile technology to improve peri-operative surgical care and communication with patients to detect impending complications. His research program at Ben Taub Hospital and Baylor St. Luke’s Medical Center offers opportunities in translational science, clinical outcomes, and mobile technology development/innovation.Dr. Suliburk also collaborates with other colleagues within Baylor College of Medicine to actively seek and develop state of the art treatments for hemorrhagic shock and severely injured trauma patients. His translational research includes the development of novel molecular markers and therapeutic targets in endocrine surgical disease (thyroid cancer, hyperthyroidism, hyperparathyroidism, and adrenal tumors), and metabolic markers of the endocrine response in severely injured major trauma patients.Dr. Suliburk received his medical degree from the University of Oklahoma College of Medicine. He completed his residency in general surgery from The University of Texas Medical School at Houston and a fellowship in endocrine surgery from Royal North Shore Hospital, University of Sydney in Sydney, Australia. He also completed an NIH T32 research fellowship from The University of Texas Medical School at Houston.Dr. Suliburk is board-certified by the American Board of Surgery. He is a fellow of the American College of Surgeons and a member of the American Thyroid Association, American Association of Endocrine Surgeons, Houston Surgical Society, Association of Academic Surgeons, American Association for the Surgery of Trauma, Surgical Infection Society, and the ACS Academy of Master Surgeon Educators.Dr. Suliburk has been named a Top Doctor in General Surgery by Houstonia Magazine (2020). He has also received numerous awards in teaching excellence from Baylor College of Medicine.
Dr. Suliburk is rated as an Experienced provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Hyperparathyroidism, Thyroid Nodule, Parathyroid Hyperplasia, Parathyroidectomy, and Thyroidectomy.
His clinical research consists of co-authoring 68 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Baylor St. Luke's - O’Quinn Medical Tower At McNair
Dr. Alastair Thompson is a surgical oncologist specializing in breast cancer. He is the Professor and Chief of the Division of Surgical Oncology, Section of Breast Surgery at Baylor College of Medicine, where he holds the Olga Keith Wiess Chair of Surgery. He also serves as Co-Director of the Lester and Sue Smith Breast Center and is Co-Associate Director for Clinical Research at the Dan L Duncan Comprehensive Cancer Center.Dr. Thomspon’s clinical interests include: ductal carcinoma in situ (DCIS); nipple and skin sparing mastectomy; breast conservation surgery; and sentinel lymph node biopsy. His research interests include: multidisciplinary patient care alongside “bench to bedside” studies; and innovative clinical trials in cancer. He initiated and led a successful breast cancer laboratory program; provided leadership for a cancer center in the United Kingdom; chaired the UK national breast cancer trials portfolio of 120 studies; and engaged in a range of pivotal roles in key drug, radiation therapy and surgical trials involving the UK, Europe, United States and Australia.Dr. Thompson also has preclinical and practical experience in the design, implementation, monitoring and reporting of early- to late-phase drug and medical device trials. Dr. Thompson received his MBChB in Medicine Surgery and medical degree in Molecular Biology from the University of Edinburgh in Edinburgh, Scotland. He completed his residency in general surgery at the Royal Infirmary of Edinburgh and a Research Fellowship at the Imperial Cancer Research Fund in Edinburgh.Dr. Thompson has co-chaired the Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial for low-risk DCIS; and the National Cancer Institute (NCI)-Breast Cancer Steering Committee proposed “no surgery” clinical trial planning committee. He is a member of the NCI BOLD taskforce and has held leadership positions in the Translational Breast Cancer Research Consortium and SWOG Cancer Research Network.Dr. Thompson is also a member of the American Society of Clinical Oncology, Association of Breast Surgery, British Association of Surgical Oncology, British Breast Group, American Society of Breast Surgeons, American Association for Cancer Research, Moynihan Chirurgical Club, and the Society of Surgical Oncology. Dr. Thompson is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Tissue Biopsy.
MD Anderson
Funda Meric is a General Surgeon and a Surgical Oncologist in Houston, Texas. Dr. Meric is rated as an Elite provider by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, Cholangiocarcinoma (Bile Duct Cancer), Triple-Negative Breast Cancer, Melanoma, and Mastectomy.
Gabriel Hortobagyi is an Oncologist in Houston, Texas. Dr. Hortobagyi is rated as a Distinguished provider by MediFind in the treatment of Breast Cancer. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Breast Cancer in Men.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- HyperparathyroidismDr. Suliburk isDistinguished. Learn about Hyperparathyroidism.
- Advanced
- Familial Isolated HyperparathyroidismDr. Suliburk isAdvanced. Learn about Familial Isolated Hyperparathyroidism.
- Neonatal Severe HyperparathyroidismDr. Suliburk isAdvanced. Learn about Neonatal Severe Hyperparathyroidism.
- Osteitis FibrosaDr. Suliburk isAdvanced. Learn about Osteitis Fibrosa.
- Parathyroid AdenomaDr. Suliburk isAdvanced. Learn about Parathyroid Adenoma.
- Parathyroid CancerDr. Suliburk isAdvanced. Learn about Parathyroid Cancer.
- Parathyroid HyperplasiaDr. Suliburk isAdvanced. Learn about Parathyroid Hyperplasia.
- Experienced
- Anaplastic Thyroid CancerDr. Suliburk isExperienced. Learn about Anaplastic Thyroid Cancer.
- AppendectomyDr. Suliburk isExperienced. Learn about Appendectomy.
- Bladder ReconstructionDr. Suliburk isExperienced. Learn about Bladder Reconstruction.
- Breast CancerDr. Suliburk isExperienced. Learn about Breast Cancer.
- CholecystitisDr. Suliburk isExperienced. Learn about Cholecystitis.
- Follicular Thyroid CancerDr. Suliburk isExperienced. Learn about Follicular Thyroid Cancer.